Ritlecitinib is a potent small molecule, acting as a selective covalent inhibitor of JAK3 and TEC kinases, currently utilized in the treatment of conditions such as alopecia areata. This category provides… Read more
![Chemical structure of (2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidine-1-carbaldehyde](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S5R-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidine-1-carbaldehyde.png&w=3840&q=75)
![Chemical structure of 1-((2R,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1792181-98-6-1-2R5R-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2R,5S)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1792180-79-0-1-2R5S-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-2-Methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2042629-43-4-1-2S5R-2-Methyl-5-5-2-prop-2-yn-1-yloxyethyl-7H-pyrrolo23-dpyrimidin-4-ylaminopiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-2-Methyl-5-((7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2S5R-2-Methyl-5-7-nitroso-7H-pyrrolo23-dpyrimidin-4-ylaminopiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-5-((1-(3-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)-3-oxopropyl)-1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2S5R-5-1-3-2S5R-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-yl-3-oxopropyl-1H-pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-5-((6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2S5R-5-67-Dihydro-5H-pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)-3-hydroxypropan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2S5R-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-yl-3-hydroxypropan-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5R)-5-(bis(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2S5R-5-bis7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 1-((2S,5S)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1792181-97-5-1-2S5S-5-7H-Pyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidin-1-ylprop-2-en-1-one.png&w=3840&q=75)
![Chemical structure of 4-(((3R,6S)-1-Acryloyl-6-methylpiperidin-3-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-3R6S-1-Acryloyl-6-methylpiperidin-3-ylamino-7H-pyrrolo23-dpyrimidine-1-oxide.png&w=3840&q=75)
![Chemical structure of Benzyl (2R,5S)-5-((2,2'-dichloro-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl)amino)-2-methylpiperidine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBenzyl-2R5S-5-22-dichloro-7H-47-bipyrrolo23-dpyrimidin-4-ylamino-2-methylpiperidine-1-carboxylate.png&w=3840&q=75)



![Chemical structure of N-((3R,6S)-1-Acryloyl-6-methylpiperidin-3-yl)-N-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-1-Acryloyl-6-methylpiperidin-3-yl-N-7-nitroso-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-1-Acryloyl-6-methylpiperidin-3-yl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-1-Acryloyl-6-methylpiperidin-3-yl-N-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-7-nitroso-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-7-tosyl-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-N-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-N-7-nitroso-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-N-(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-N-7-tosyl-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methyl-1-nitrosopiperidin-3-yl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methyl-1-nitrosopiperidin-3-yl-N-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methylpiperidin-3-yl)-7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methylpiperidin-3-yl-7-nitroso-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methylpiperidin-3-yl)-N-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methylpiperidin-3-yl-N-7-nitroso-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methylpiperidin-3-yl)-N-(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methylpiperidin-3-yl-N-7-tosyl-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methylpiperidin-3-yl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methylpiperidin-3-yl-N-7H-pyrrolo23-dpyrimidin-4-yl-7H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of N-((3R,6S)-6-Methylpiperidin-3-yl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)nitrous amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3R6S-6-Methylpiperidin-3-yl-N-7H-pyrrolo23-dpyrimidin-4-ylnitrous-amide.png&w=3840&q=75)
![Chemical structure of N-((3S,6R)-6-Methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-3S6R-6-Methylpiperidin-3-yl-67-dihydro-5H-pyrrolo23-dpyrimidin-4-amine.png&w=3840&q=75)




Ritlecitinib is a potent small molecule, acting as a selective covalent inhibitor of JAK3 and TEC kinases, currently utilized in the treatment of conditions such as alopecia areata. This category provides an essential collection of Ritlecitinib reference standards, including the active pharmaceutical ingredient, associated metabolites, and synthetic impurities. Laboratories rely on these high-quality materials for critical analytical procedures, including rigorous impurity profiling, stability testing, and method validation to ensure regulatory compliance. The inclusion of stable isotope labelled compounds facilitates precise quantification during bioanalytical studies and quality control processes. By utilizing these pharmacopeial and non-pharmacopeial reference standards—which encompass process-related compounds, degradation products, and potential contaminants—researchers and analytical chemists can maintain consistent standards for product safety and therapeutic efficacy in accordance with established ICH guidelines.